QIAstat-Dx uses real-time PCR technology to multiply genetic targets within the same reaction and deliver test results in around one hour.

Mersana on Friday said the new designation covers the drug, XMT-1660, for the treatment of advanced or metastatic breast cancer in patients with human epidermal growth factor receptor 2 low or ...

The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study ...

U.S. government report on “notorious markets” known for counterfeiting and other violations of intellectual property says ...

Biotech competition between the U.S. and China "will not only have implications for our national and economic security, but also for the future of healthcare and the security of American medical data, ...

South Florida specialists want people to know that repairing your liver is possible, and laying off alcohol in January is only one way to kick-start the process. The liver performs more than 500 ...

A2 Biotherapeutics has secured $80m in funding to advance its pipeline of CAR-T cell therapies for solid tumour cancers.

The cost of a carton is soaring nationwide, breaking new records as the bird flu outbreak grows. Zoom out: A dozen large eggs ...

Following acceptance of a protocol amendment, Rhythm expects to begin dosing patients with acquired HO in Part C of the Phase ...

Medicare has announced the expansion of coverage for Eli Lilly’s Zepbound, a breakthrough drug in the treatment of autoimmune ...

Additionally, rapid, substantial and sustained statistically significant reductions in 17-OHP, a confirmatory secondary biomarker of disease control, were achieved across doses. Treatment with ...